![ASH launches sickle cell disease clinical trials network to accelerate therapy development | oneSCDvoice ASH launches sickle cell disease clinical trials network to accelerate therapy development | oneSCDvoice](https://www.onescdvoice.com/wp-content/uploads/2019/01/ash.jpg)
ASH launches sickle cell disease clinical trials network to accelerate therapy development | oneSCDvoice
![UC Consortium Launches First Clinical Trial Using CRISPR to Correct Gene Defect That Causes Sickle Cell Disease | UC San Francisco UC Consortium Launches First Clinical Trial Using CRISPR to Correct Gene Defect That Causes Sickle Cell Disease | UC San Francisco](https://www.ucsf.edu/sites/default/files/styles/article_feature_banner__image/public/2021-03/Sickle-Cell-1920x1000.jpg)
UC Consortium Launches First Clinical Trial Using CRISPR to Correct Gene Defect That Causes Sickle Cell Disease | UC San Francisco
![Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials - Experimental Hematology Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials - Experimental Hematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f2a6d4c2-fd31-4fc9-8501-0a5f95a3027b/fx1.jpg)
Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials - Experimental Hematology
![PDF] Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial. | Semantic Scholar PDF] Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b2af0936c5ca1c3939a3cc0464bb73b9531b5b3a/4-Table2-1.png)
PDF] Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial. | Semantic Scholar
![A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers - ScienceDirect A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952921005887-grabsf1.jpg)
A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers - ScienceDirect
![FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease | Berkeley News FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease | Berkeley News](https://news.berkeley.edu/wp-content/uploads/2021/03/Sickle-Cell-750x500-1.jpg)